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Abstract 
 
Learng Pid Samud (LPS) recipe is a traditional remedy in Thai folk medicine to ease the common diarrhea. The 
anti-diarrheal potential of LPS recipe was herein examined in vitro using a guinea-pig ileum model. The LPS exerted an 
inhibitory effect on acetylcholine-induced smooth muscle contraction in the guinea pig ileum. Significantly, not only did the 
LPS reduce the total amount of feces in the induced diarrhea rats, but also the intestinal transit in the charcoal meal test. A 
single oral administration with the recipe at 5,000 mg/kg did not cause acute toxicity and the daily oral administration (1,000, 
2,000 and 4,000 mg/kg) for 90 days in rats did not produce any toxic signs and symptoms. In conclusion, the Learng Pid 
Samud recipe remedy is evidently safe and effective for the anti-diarrheal treatment which supports its therapeutic uses in the 
alternative medicine.   
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Introduction 
 
Diarrhea is one of the most common illnesses in all age groups. It is an uncomfortable condition that can have 
many causes, and vital gastroenteritis (stomach flu) is one of the most common causes of diarrhea. Diarrhea will normally 
heal itself within a few days. However, in some cases, diarrhea can lead to dehydration or be a sign of a more serious 
problem (Fontaine, 1988; Snyder and Merson, 1982).  
Learng Pid Samud (LPS) recipe is a household remedy in the National List of Essential Medicines of Thailand, for 
the treatment of non-infectious diarrhea. According to the applied Thai traditional medicine, this recipe is composed of 
fourteen kinds of herbal plants as shown in Table 1 (National Drug Committee, Ministry of Public Health, 2006). All plants 
in LPS recipe except resin from plants in Dipterocarpaceae family and resin of L. chinensis show gastrointestinal effects and 
anti-diarrheal activity (Rajkumar et al., 2011; Chengaiah et al., 2010; Meena et al., 2010; Rabbani et al., 2010; Sawangjaroen 
and Sawangjaroen, 2005; Taufiq-Ur-Rahman et al., 2005; Rabbani et al., 2004; Sharma et al., 2001; Das et al., 1999; Joy et 
al., 1998). However, the scientific data to support the reputed anti-diarrheal activity and toxicity of the LPS recipe have not 
yet been substantiated. Therefore, the objective of this study was to evaluate the anti-diarrheal activity and safety of this 
recipe.  
 
 
Materials and methods 
Preparation of Learng Pid Samud (LPS) extract 
 
The constituents of LPS are listed in Table 1. The 14 kinds of plant materials were kindly provided by the Center of 
Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University. The plant was identified and 
kept at the herbarium library collection at Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. Each plant material 
was 4.80 kg, but C. longa was 28.80 kg. Whole plant material (91.20 kg) was continuously extracted with three solvents, n-
hexane, 95% ethanol and hot water, and spray dried.  
 
Standardization of LPS extract 
 
The quality control of raw materials and the extract was followed by Thai Herbal Pharmacopoeia including 
organoleptic examination, % loss on drying, extractive values, total ash and acid insoluble ash (Department of Medical 
Sciences, 2000). The percent amount of volatile oil, type of chemical constituents in oils (detected by GC/MS), chemical 
constituents in raw materials and the extract were also studied using thin layer chromatography (TLC) following the method 
of Farnsworth (Farnsworth, 1966). 
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Experimental animals 
 
Male Sprague-Dawley rats (140-180 and 180-200 g), female Sprague-Dawley rats (180-200 g) and male or female 
Guinea pig (500-700 g) were provided by the National Laboratory Animal Center, Mahidol University, Nakorn Pathom, 
Thailand. The animals were housed under standard environmental conditions of temperature at 24 ± 1 C under a 12 h dark-
light cycle, and allowed free access to drinking water and standard pellet diet. The experimental protocols were authorized by 
the Animal Ethics Committee of Faculty of Medicine, Thammasat University, Pathumthani, Thailand (No. 0003/2007). 
 
 
Table 1 Composition of LPS  
Scientific name Family Part of used 
Cyperus rotundus Linn GRAMINEAE Root  
Curcuma zedoaria (Berg) Roscoe ZINGIBERACEAE Rhizome  
Oroxylum indicum (L.) Kurz BIGNONIACEAE Bark  
Musa (ABB group) MUSACEAE Root  
Allium sativum L. ALLIACEAE Bulb  
Uncaria gambir (Hunter) Roxb RUBIACEAE Branch 
Acacia catechu (L.f.) Willd LEGUMINOSAE Branch 
Lawsonia inermis L. LYTHRACEAE Leaf   
Punica granatum Linn. vas granatum PUNICACEAE Leaf  
Piper chaba Hunt PIPERACEAE Fruit  
Curcuma longa Linn. ZINGIBERACEAE Rhizome  
Laccifera chinensis Mahdihassan LACCIFERIDAE Resin  
Hopea odorata Roxb., Dipterocarpus alatus 
Roxb., Dipterocarpus intricatus Dyer, Shorea 
henryana Pierre,  
Shorea btuse Wall.,  
Shorea siamensis Miq. 
DIPTEROCARPACEAE Resin 
Quercus infectoria Oliver FAGACEAE Gall 
 
 
Isolated guinea pig ileum experiment 
 
Briefly, Guinea pigs of both sexes were fasted 48 hour before the experiment. After the animals were sacrificed, the 
midline incision of the abdomen was made and the ileum was isolated. The ileum was cut into strips of 2 cm long. A piece of 
ileum was mounted in a bath of 20 ml Tyrode’s solution (NaCl = 8.0, KCl = 0.2, MgCl2 = 0.1, CaCl2 = 0.2, NaH2PO4 = 0.05, 
NaHCO3 = 1.0, and glucose = 1 g/L) with a controlled temperature of 37 C and aerated with 95% O2 and 5% CO2. Isometric 
concentrations were recorded under a resting tension of 1 g via a force displacement transducer (FTO3 Grass Instrument Co., 
Quincy, MA) and displayed on a polygraph (PD7, grass Instrument Co.). After an equilibration period of 30 min, standard 
contractions produced by acethylcholine (ACh, 0.02 ug/mL) were recorded. The tissue was then washed out with Tyrode’s 
solution. To test the inhibitory effect, the test substance was added into the organ-bath 3 minutes before the addition of ACh. 
The tissue was further washed 3-4 times after measuring the contractions at each dose of test substances. Results are 
expressed as percent inhibition of contraction (Department of Pharmacology, University of Edinburg, 1970).   
 
Castor oil-induced diarrhea in rats 
 
Mice were fasted 48 h, and water was given ad libitum. The water was withdrawn 1 h before starting the 
experiment. The experiment was performed according to the method of Venkatesan et al. (2005). Mice were given 0.5% 
carboxymethy cellulose (CMC) (orally) or LPS (orally) or atropine sulfate (intraperitoneally, i.p.). One hour later, they were 
given one milliliter castor oil orally and then weighed and placed individually in a transparent plastic box with absorbent 
paper underneath. Total amount of feces (in grams) after the castor oil administration was collected and weighed. 
 
Small intestinal transit in rats 
 
The experiment was performed according to the method of Venkatesan et al. (2005). Rats were fasted 48 h, and 
water was given ad libitum. The water was withdrawn 1 h before starting the experiment. The rats were given 0.5% CMC or 
LPS (orally) or atropine sulfate (i.p). Thirty minutes later, they were orally fed with 1 ml of 3% deactivated charcoal (in 0.5% 
CMC). Thirty minutes after the deactivated charcoal feeding, the rats were sacrificed with intraperitoneal injection of 
pentobarbital sodium (50 mg/kg) and the gastrointestinal tract was removed. Total length of the small intestine (pylorus to 
caecum), and the distance of the deactivated charcoal movement were measured. The small intestine transit was calculated 
and expressed as percentage of the deactivated charcoal movement.  
 
 
Acute oral toxicity 
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Acute oral toxicity test was performed according to the World Health Organization (WHO) guideline (WHO, 2000) 
and the Organization of Economic Co-operation and Development (OECD) guideline for testing of chemicals TG420 
(OECD, 2001). Healthy fasted rats (five rats per group) were administrated a single oral dose of 5,000 mg/kg body weight 
while the control group received water vehicle. Body weight, signs of toxicity and mortality were observed after the 
administration at the first, second, fourth and sixth hour and once daily for next 14 days. On the 15th day, all rats were kept 
fasted for 16-18 hours, and then sacrificed with pentobarbital sodium (50 mg/kg, i.p.) for necropsy examination. The internal 
organs were excised and weighed. The gross pathological observations of the tissues were performed.  
 
Subchronic oral toxicity  
 
According to WHO guideline (WHO, 2000) and the OECD TG408 (OECD, 1981), rats were divided into 6 groups 
of 20 animals (10 male and 10 female). The extract was administered orally at doses of 1,000, 2,000 and 4,000 mg/kg body 
weight to the three subsequent treatment groups for consecutive 90 days, while the control group received distilled water. 
Signs of toxicity, mortality and body weight changes were monitored daily.  
At the end of the experiment, all animals were kept fasted for 16-18 h and then anesthetized with intraperitoneal injection of 
pentobarbital sodium at a dose of 50 mg/kg on day 91st and 118th (satellite groups). Blood samples for hematological and 
blood chemical analyses were taken from common carotid artery. The internal organs and some tissues were weighed to 
determine relative organs’ weights and observed for gross lesions. All tissues were preserved in 10% neutral buffered 
formaldehyde solution for histopathological examination.  
 
Statistical analysis 
 
Data were reported as mean ± standard error of mean (S.E.M.) and were compared using one-way analysis of 
variance (ANOVA), followed by post hoc least-significant difference test. The data obtained from acute toxicity studies were 
analyzed using Student’s paired t-test. P values less than 0.05 were considered to be significant. 
 
 
Results 
LPS extract 
 
The raw materials of LPS contained 14 varieties of plants. The chemical constituents in the raw materials were 
mainly fluorescence compounds (green, blue or red color), terpenes and tannins. The amount of tannin is present in six plants 
of this recipe including Q. infectoria (69.40%), U. gambir (45.10%), P. granatum var. granatum (24.94%), L. inermis 
(8.56%), A. catechu (7.98%), and Musa (ABB group) (2.04%). Four plants contained volatile oil: C. longa (6.92%), C. 
zedoaria (2.58%), P. chaba (0.95%), and C. rotundus (0.75%). Continuous extraction of crude extracts by three solvents: 
hexane, 95% ethanol and water gave two separate fractions in ratio of 4:1 w/w. The texture of the first extract was brown and 
sticky resin (16.48 kg) and the latter was yellow and fine powder (4.12 kg). Both fractions were combined and used for 
testing in further experiments. The percent yield of raw material was 22.59 %w/w. 
 
Anti-diarrheal activity  
 
As shown in Figure 1, the positive control atropine sulfate (30 ng/ml) effectively inhibited the ACh-induced ileum 
contraction by 81.11%. Similarly, LPS at the concentrations of 0.25, 0.50 and 1.00 mg/ml significantly inhibited the ACh-
induced contractions (20-80%) in a concentration-dependent manner. The anti-diarrheal effect of LPS was further examined 
in vivo using experimental rats. The diarrhea in rats was induced by castor oil, and the total amount of feces in 4 h was 
recorded as shown in Figure 2. Atropine as well as LPS significantly showed > 50% decrease in the total amount of feces. 
Finally, the gastrointestinal motility was measured in rats, and the result clearly demonstrated that LPS, similar to atropine 
sulfate, effectively decreased the movement of deactivated charcoal from the stomach to the small intestine (Figure 3). 
 
Acute oral toxicity 
 
LPS at a dose of 5,000 mg/kg did not show any toxicity during the experimentation period. The internal organs of 
treatment rats such as brain, lung, heart, liver, spleen, adrenal gland, kidney, and sex organ showed no pathological 
abnormality relative to these organs of the control (data not shown). 
 
Subchronic oral toxicity 
 
The subchronic oral administration of LPS (1,000, 2,000 and 4,000 mg/kg) resulted in no significant change in 
neither general behavior nor in health condition during the experimentation period. The body weights and weight gain of both 
female and male rats at various concentrations are listed in Table 2. The female rats (2,000 and 4,000 mg/kg) showed a 
significant decrease of the body weight gain from those of the control. Moreover, the male rats showed a significant decrease 
in the body weights (day 90th) and body weight gain in comparison with the control groups. Some internal organ weights of 
the treatment female and male rats significantly lower than that of the control (Table 3 and 4). For 1,000 and 2,000 
mg/kg/day dose, a significant increase in mean corpuscular volume (MCV) in the female treatment rats was observed (Table 
5). The female rats in the group treated with 4,000 mg/kg body weight showed the significantly increased mean corpuscular 
hemoglobin concentration (MCHC) more than that in the control group. In the male groups, MCV and mean corpuscular 
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hemoglobin (MCH) in treated group with 4,000 mg/kg body weight was significantly higher than those in the control group 
(Table 6).  The differential white blood cell count values of the female and male rats treated groups are shown in Table 7 and 
8, respectively. In the female treatment rats, a significant decrease in monocyte was observed in the treated groups with 
1,000, 4,000 mg/kg and satellite group. The eosinophil of female treatment rats (1,000 and 2,000 mg/kg) were significantly 
increased from those of the female control. Furthermore, a significant decrease in neutrophil was observed in the male 
satellite group. Blood chemical value of the female and male rats treated groups are summarized in Table 9 and 10, 
respectively. In the female and male treatment rats, some parameters of these values were significantly difference than that of 
the control group. 
 
Figure 1 The inhibitory effect of atropine sulfate and LPS extract on acetylcholine-induced contraction of isolated guinea pig 
ileum. * Significantly different from control, p<0.05 
 
 
Figure 2 Effect of atropine sulfate and LPS extract on total feces amounts (g) after 4 h castor oil-induced diarrhea in rats. * 
Significantly different from control, p<0.05 
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Figure 3 The inhibitory effect of atropine sulfate and LPS extract on charcoal movement in gastrointestinal tract of rats. * 
Significantly different from control, p<0.05 
 
 
 
 
 
 
Table 2: Body weights of rats under subchronic doses of LPS 
Body weight (g)  
Day 0 Day 90 Day 118 Weight gain on day 
90 
Female     
Control 235.40 ± 4.89 280.40 ± 9.96 - 47.00 ± 6.27 
Control a 251.20 ± 2.33 282.80 ± 7.08 286.00 ± 6.06 31.60 ± 7.82 
LPS      
1,000 mg/kg 245.20 ± 3.97 282.40 ± 3.65 - 37.20 ± 4.77 
2,000 mg/kg 246.00 ± 3.07 271.80 ± 3.85 - 25.80 ± 3.57* 
4,000 mg/kg 249.40 ± 5.19* 264.00 ± 4.11* - 16.40 ± 4.99* 
4,000 mg/kg a 242.40 ± 6.07 273.10 ± 3.40 275.60 ± 2.28 34.90 ± 5.02 
Male     
Control 243.60 ± 4.77 380.00 ± 11.15 - 138.20 ± 13.53 
Control a 238.20 ± 7.09 358.80 ± 13.00 357.60 ± 14.51 120.60 ± 15.34 
LPS      
1,000 mg/kg 235.40 ± 6.16 327.80 ± 11.22* - 92.40 ± 9.85* 
2,000 mg/kg 234.80 ± 3.74 319.60 ± 13.69* - 84.80 ± 11.93* 
4,000 mg/kg 245.20 ± 6.06 347.00 ± 6.67* - 101.80 ± 8.14* 
4,000 mg/kg a 235.80 ± 6.46 336.60 ± 7.89* 323.20 ± 7.07 100.80 ± 6.71* 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
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Table 3 Organ weights of female rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Lung  1.98 ± 0.31 2.00 ± 0.20 1.72 ± 0.30 2.22 ± 0.31 1.59 ± 0.12 1.45 ± 0.10 
Heart  1.32 ± 0.04 1.24 ± 0.04 1.15 ± 0.05* 1.13 ± 0.05* 1.21 ± 0.04 1.16 ± 0.03 
Liver  8.95 ± 0.48 8.24 ± 0.40 8.30 ± 0.40 8.92 ± 0.32 9.26 ± 0.20 7.00 ± 0.02 
Spleen  0.84 ± 0.03 0.78 ± 0.04 0.69 ± 0.03* 0.87 ± 0.11 0.77 ± 0.02 0.70 ± 0.03 
Adrenal gland  0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.02 ± 0.00 
Kidney  1.38 ± 0.16 1.26 ± 0.04 1.38 ± 0.05 1.31 ± 0.03 1.32 ± 0.05 1.24 ± 0.05 
Testis  1.69 ± 0.18 1.63 ± 0.08 1.60 ± 0.04 1.54 ± 0.01 1.77 ± 0.03 1.71 ± 0.04 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days.* Significantly different from control, p<0.05. 
 
Table 4 Organ weights of male rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Lung  1.76 ± 0.26 1.80 ± 0.15 1.53 ± 0.13 1.49 ± 0.09 1.70 ± 0.12 1.35 ± 0.14 
Heart  0.96 ± 0.03 1.00 ± 0.02 0.97 ± 0.03 0.92 ± 0.02 1.05 ± 0.03* 0.96 ± 0.10 
Liver  5.95 ± 0.26 6.44 ± 0.19 6.56 ± 0.16* 6.35 ± 0.13 7.37 ± 0.24* 6.48 ± 0.68 
Spleen  0.70 ± 0.03 0.69 ± 0.04 0.70 ± 0.02 0.68 ± 0.02 0.70 ± 0.02 0.74 ± 0.08 
Adrenal gland  0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 
Kidney  1.01 ± 0.04 0.94 ± 0.02 0.98 ± 0.02 0.94 ± 0.02* 0.99 ± 0.11 0.96 ± 0.09 
Ovary  0.05 ± 0.00 0.0 ± 0.01 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.01 0.05 ± 0.01 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
 
Table 5 Hematological examinations of female rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Red blood cell (x106/l) 7.81 ± 0.11 7.95 ± 0.29 7.74 ± 0.09 7.88 ± 0.10 7.59 ± 0.09 7.70 ± 0.17 
Hemoglobin (g/dl) 14.71 ± 0.22 14.86 ± 0.48 14.76 ± 0.21 14.97 ± 0.20 14.39 ± 0.18 14.67 ± 0.30 
Hematocrit (%) 42.52 ± 0.56 42.58 ± 1.49 42.56 ± 0.57 43.33 ± 0.51 40.99 ± 0.44 42.01 ± 0.87 
MCV(fl) 54.47 ± 0.18 53.54 ± 0.26 55.00 ± 0.13* 55.03 ± 0.20* 54.00 ± 0.13 54.64 ± 0.17 
MCH (pg) 18.84 ± 0.14 18.66 ± 0.14 19.08 ± 0.07 19.02 ± 0.08 18.94 ± 0.06 19.04 ± 0.08 
MCHC (g/dl) 34.57 ± 0.21 34.90 ± 0.17 34.69 ± 0.06 34.57 ± 0.10 35.10 ± 0.11* 34.85 ± 0.09 
Platelet (x105/l) 5.53 ± 0.12 5.68 ± 0.09 5.66 ± 0.15 5.89 ± 0.11 5.85 ± 0.15 5.65 ± 0.21 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days.* Significantly different from control, p<0.05. 
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Table 6: Hematological examinations of male rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Red blood cell (x106/l) 8.70 ± 0.07 8.84 ± 0.10 8.18 ± 0.17 8.40 ± 0.20 13.33 ± 4.96 8.84 ± 0.10 
Hemoglobin (g/dl) 15.90 ± 0.11 15.92 ± 0.20 15.05 ± 0.29 15.51 ± 0.39 15.52 ± 0.35 15.43 ± 0.50 
Hematocrit (%) 43.08 ± 3.31 46.66 ± 0.59 43.87 ± 0.91 44.94 ± 1.08 45.22 ± 0.97 44.93 ± 1.40 
MCV(fl) 53.34 ± 0.20 52.78 ± 0.22 53.66 ± 0.30 53.52 ± 0.25 54.27 ± 0.24* 52.74 ± 0.23 
MCH (pg) 18.29 ± 0.08 18.02 ± 0.10 18.40 ± 0.39 18.46 ± 0.09 18.62 ± 0.09* 18.11 ± 0.06 
MCHC (g/dl) 34.42 ± 0.13 34.12 ± 0.12 34.31 ± 0.19 34.46 ± 0.10 34.33 ± 0.12 33.34 ± 0.14 
Platelet (x105/l) 5.79 ± 0.21 5.55 ± 0.15 5.78 ± 0.17 5.61 ± 0.32 5.59 ± 0.23 5.82 ± 0.12 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
 
Table 7: Differential white blood cell counts of female rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
White blood cell (x103/l) 2.33 ± 0.13 2.40 ± 0.17 2.46 ± 0.09 2.33 ± 0.08 2.51 ± 0.15 2.51 ± 0.13 
Neutrophil (%) 15.99 ± 1.90 20.52 ± 3.99 15.51 ± 2.05 15.35 ± 1.25 13.26 ± 1.32 12.94 ± 0.85 
Lymphocyte (%) 79.34 ± 2.18 76.32 ± 4.92 80.67 ± 2.22 79.23 ± 1.14 84.61 ± 1.71 84.23 ± 1.03 
Monocyte (%) 1.66 ± 0.55 0.24 ± 0.09* 0.55 ± 0.21* 1.61 ± 0.46 0.20 ± 0.11* 0.40 ± 0.15* 
Eosinophil (%) 0.83 ± 0.27 1.50 ± 0.53 1.96 ± 0.32* 2.05 ± 0.34* 1.02 ± 0.43 0.84 ± 0.41 
Basophil (%) 2.00 ± 0.33 1.46 ± 0.62 1.32 ± 0.48 1.75 ± 0.35 0.91 ± 0.21 1.59 ± 0.64 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
 
Table 8: Differential white blood cell counts of male rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
White blood cell (x103/l) 2.53 ± 0.10 2.58 ± 0.14 2.62 ± 0.13 2.88 ± 0.17 2.83 ± 0.13 2.51 ± 0.10 
Neutrophil (%) 19.62 ± 1.63 14.91 ± 3.04 15.54 ± 2.07 15.46 ± 2.67 16.33 ± 1.88 11.78 ± 1.62* 
Lymphocyte (%) 77.88 ± 1.98 82.52 ± 3.17 75.39 ± 3.07 81.91 ± 3.04 78.72 ± 1.57 85.17 ± 1.99 
Monocyte (%) 0.70 ± 0.14 0.72 ± 0.37 2.63 ± 1.96 0.46 ± 0.12 1.36 ± 0.81 1.20 ± 0.82 
Eosinophil (%) 0.81 ± 0.41 0.22 ± 0.11 0.82 ± 0.29 0.74 ± 0.33 1.12 ± 0.36 0.51 ± 0.29 
Basophil (%) 1.12 ± 0.17 1.61 ± 0.51 0.53 ± 0.15 1.26 ± 0.38 1.51 ± 0.31 1.35 ± 0.40 
Values expressed as mean ± S.E.M (n = 10) 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
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Table 9:  Clinical blood chemistry examinations of female rats under subchronic doses of LPS 
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Glucose (mg/dl) 86.89 ± 3.15 90.80 ± 4.19 88.30 ± 2.23 88.10 ± 2.73 99.67 ± 3.42* 97.44 ± 1.03* 
BUN (mg/dl) 23.67 ± 0.80 26.00 ± 0.65 24.50 ± 0.87 25.00 ± 0.92 23.67 ± 0.73 26.89 ± 0.68* 
Creatinine (mg/dl) 0.60 ± 0.02 0.68 ± 0.04 0.66 ± 0.03 0.60 ± 0.02 0.51 ± 0.02* 0.58 ± 0.02 
Total protein (g/dl) 5.93 ± 0.06 5.86 ± 0.10 6.21 ± 0.05* 6.03 ± 0.10 6.02 ± 0.12 5.76 ± 0.13 
Albumin (g/dl) 1.50 ± 0.05 1.58 ± 0.02 1.64 ± 0.03* 1.51 ± 0.02 1.64 ± 0.05* 1.61 ± 0.05 
Total bilirubin (mg/dl) 0.47 ± 0.03 0.40 ± 0.05 0.45 ± 0.03 0.43 ± 0.02 0.47 ± 0.02 0.36 ± 0.04* 
Direct bilirubin (mg/dl) 0.16 ± 0.02 0.12 ± 0.04 0.12 ± 0.02 0.10 ± 0.02 0.16 ± 0.02 0.08 ± 0.02* 
SGOT (U/l) 106.00 ± 1.85 85.20 ± 6.08* 107.20 ± 2.11 106.00 ± 1.83 95.78 ± 2.56* 94.44 ± 2.52* 
SGPT (U/l) 36.67 ± 2.02 31.40 ± 1.81 35.80 ± 1.62 31.50 ± 1.49* 30.00 ± 1.87* 34.11 ± 1.09 
ALP (U/l) 51.89 ± 4.42 47.20 ± 4.99 43.70 ± 1.97* 44.30 ± 1.44* 40.56 ± 1.84* 49.89 ± 1.74 
Values expressed as mean ± S.E.M (n = 10)   * Significantly different from control, p<0.05. 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days.  
 
Table 10: Clinical blood chemistry examinations of male rats under subchronic doses of LPS  
LPS (mg/kg)   
Control 
 
Control a 1,000 2,000 4,000 4,000 a 
Glucose (mg/dl) 78.11 ± 3.91 94.50 ± 3.01* 70.30 ± 2.84 77.22 ± 2.94 91.90 ± 3.02* 86.10 ± 3.35 
BUN (mg/dl) 19.11 ± 1.06 23.40 ± 0.87* 22.40 ± 1.30* 23.78 ± 1.13* 26.10 ± 1.40* 21.80 ± 0.83 
Creatinine (mg/dl) 0.58 ± 0.03 0.58 ± 0.02 0.49 ± 0.02 0.51 ± 0.03 0.49 ± 0.06 0.53 ± 0.01 
Total protein (g/dl) 5.96 ± 0.11 5.74 ± 0.13 5.89 ± 0.12 5.98 ± 0.24 6.09 ± 0.09 5.62 ± 0.06 
Albumin (g/dl) 1.50 ± 0.08 1.33 ± 0.03* 1.43 ± 0.05 1.43 ± 0.09 1.47 ± 0.03 1.39 ± 0.04 
Total bilirubin (mg/dl) 0.41 ± 0.03 0.45 ± 0.02 0.40 ± 0.01 0.47 ± 0.03 0.43 ± 0.03 0.41 ± 0.02 
Direct bilirubin (mg/dl) 0.12 ± 0.03 0.11 ± 0.02 0.10 ± 0.02 0.13 ± 0.04 0.10 ± 0.03 0.11 ± 0.01 
SGOT (U/l) 135.00 ± 4.97 95.40 ± 2.90* 130.90 ± 3.48 126.56 ± 5.34 113.70 ± 7.51* 104.50 ± 1.09* 
SGPT (U/l) 38.33 ± 1.62 36.50 ± 1.79 37.40 ± 1.59 39.89 ± 0.93 35.60 ± 153 31.60 ± 1.65* 
ALP (U/l) 66.22 ± 2.96 51.90 ± 3.47* 69.50 ± 2.06 72.22 ± 1.49 72.70 ± 1.84 53.50 ± 3.06* 
Values expressed as mean ± S.E.M (n = 10)   * Significantly different from control, p<0.05. 
a: a satellite group was treated with oral dose of test substance for 90 days following by no treatment for 28 days 
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Discussion 
 
Learng Pid Samud is used as anti-diarrheal remedy in Thai folk medicine. In the present study, the anti-
diarrhea activity of this recipe was verified in vitro (isolate guinea-pig ileum) and in vivo (small intestinal transit 
and castor oil-induced diarrhea in rats). Diarrhea is a condition in which the frequency of bowel movements is 
increased or the form of stool decreased. The effects such as inhibition of ileum contractions, slowing motility and 
propulsion of intraluminal contents are generally known to take part in anti-transit effect (Shook et al., 1989). 
Gastrointestinal (GI) transit may be coordinated by relaxation of the circular muscle and constriction of the 
longitudinal muscle (Prins et al., 2000; Shibata et al., 1999). Nerve supply of GI tract has two types, enteric system 
(myenteric and submucosal plexus) and extrinsic nerves (parasympathetic and sympathetic nerves). The enteric 
system controls the movement and secretion within the gut. The stimulation of parasympathetic nerves lead to the 
increase of motility and secretion within the tract and relaxation of the gut sphincters. In contrast, the sympathetic 
nerves reduce blood flow to the gut, and decrease secretions, motility and contractions (Ganong, 2001).  
ACh is a neurotransmitter from parasympathetic nervous system. It acts on muscarinic and nicotinic 
cholinergic receptors. This neurotransmitter produces a contractile response in the ileum. Atropine is a competitive 
antagonist for the muscarinic ACh receptor (Pappano and Kutzung, 2004). In this study, LPS as well as atropine 
sulfate showed an inhibitory effect on ACh-induced contractions of isolated guinea pig ileum. Thus, the anti-
spasmodic activity of LPS may involve a cholinergic mechanism. 
The castor oil test in rats has been extensively used to screen and assess anti-diarrhea agents. This test is 
both secretion and motility diarrhea model (Yegnanaravan and Shrotri, 1982). Castor oil causes diarrhea due to the 
irritating properties of its active ricinoleic acid. Ricinoleic acid (hydroxyl fatty acid) increases the peristalsis 
activity, decreases the small intestinal transit time and produces a permeability change in the intestinal mucosal 
membrane to electrolytes and water resulting in a hypersecretory response (Kutchai, 2004; Gaginella et al., 1975; 
Ammon et al., 1974). Moreover, its irritating properties are a cause of the inflammation of intestinal mucosal 
membrane, leading to the release of prostaglandins, which stimulates the small intestinal movement and water and 
electrolytes secretion (Beubler and Juan, 1979; Pierce et al., 1971). The reduction in severity and frequency of 
defecation can be attributed to the anti-intraluminal fluid accumulation activity (Nwodo and Alumanah, 1991). The 
increase in intestinal transit time by atropine could also take place due to the reduction in gastric emptying (Izzo et 
al., 1999). Atropine produces the reduction in the number of stools and increases the intestinal transit time possibly 
due to its anti-cholinergic effect (Brown and Taylor, 2000). In this experimental model, LPS effectively decreases 
the total amount of feces in 4 hours after castor oil administration. These results suggest the LPS and atropine may 
share a similar mechanism of action.  
The effect of LPS on small intestinal transit was examined using deactivated charcoal with atropine 
sulfate as the reference drug. Similar to atropine, the LPS recipe lessened the moving distance of deactivated 
charcoal through the ileum. These results suggest that the mechanism of LPS’s anti-diarrheal activity may be due 
to the slowing propulsion of intraluminal contents and/or inhibition of the ileum contraction. 
Acute oral toxicity and subchronic oral toxicity tests were further studied in rats to assess the safety of 
LPS. In acute toxicity, a single oral administration of LPS (5,000 mg/kg) was given to both sexes of rats. This 
recipe did not significantly change the body weight and the internal organ weight of treated female and male rats. 
There were no significant differences in general behaviors and toxic signs. Gross and pathological examinations of 
the internal organs revealed no pathological abnormality. The results suggest that LPS is not toxic after a single 
oral administration.   
For the subchronic toxicity test, the observed changes such as toxic signs, animal behavior, health 
monitoring, final body and organ weights are attributable to usual change in food intake or metabolism. Neither 
morbidity nor sickness was observed during the entire experimentation period. The results show a significant 
increase in the body weight of the male rats when compared with the control groups. Moreover, significant 
changes in the hematological values and biochemical examination fall within the normal ranges (Angkhasirisap et 
al., 2002; Inala et al., 2002; Caisey and King, 1980). Necropsy and histopathological examinations further confirm 
no macroscopic or microscopic changes in these internal organs or tissues in any treated rats.  
In conclusion, Learng Pid Samud recipe has an effective anti-diarrheal activity and no toxicity which 
supports its therapeutic uses in traditional medicine for treatment of diarrhea.   
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